科瑞產(chǎn)品

- 客戶定制產(chǎn)品 - 前列腺素系列 - PI3K Inhibitors - C-Kit Inhibitors - VEGFR Inhibitors - mTOR Inhibitors - c-Met Inhibitors - DNA/RNA Inhibitors - HER2 Inhibitors - Raf Inhibitors - JAK Inhibitors - Others - SRC Inhibitors - AKT Inhibitors - CDK Inhibitors

浙江省臺州市椒江開發(fā)大道東段288號萬達廣場2號樓

0576-88813233

0576-88670057

sales@crene.cn

合作客戶/Partner

當前位置：科瑞產(chǎn)品

BGC-20-1531

規(guī)格	價格	庫存	數(shù)量
在線咨詢大包裝詢價加入購物車

如您需要更多數(shù)量的報價，請點擊立即獲取報價或者通過電子郵件sales@crene.cn把您需要的數(shù)量信息提交給我們我們會在第一時間回復您，謝謝！

產(chǎn)品信息

產(chǎn)品名稱：BGC-20-1531	純度：98% min
CAS NO：1186532-61-5	溶解度：
分子式：C₂₆H₂₃N₂NaO₆S	包裝：可按客戶要求包裝
分子量：514.525	貯存：-20 ℃

質(zhì)量控制

備注說明

BGC201531, also known as GTPL3380 and AP-1531, is a EP4 antagonist for the treatment of acute migraine.

參考文獻

1: Antonova M, Wienecke T, Maubach K, Thomas E, Olesen J, Ashina M. The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the prostaglandin E2 human model of headache. J Headache Pain. 2011 Oct;12(5):551-9. doi: 10.1007/s10194-011-0358-9. Epub 2011 Jun 17. PubMed PMID: 21681585; PubMed Central PMCID: PMC3173651.

2: Maubach KA, Davis RJ, Clark DE, Fenton G, Lockey PM, Clark KL, Oxford AW, Hagan RM, Routledge C, Coleman RA. BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headache. Br J Pharmacol. 2009 Jan;156(2):316-27. doi: 10.1111/j.1476-5381.2009.00027.x. Epub 2009 Jan 19. PubMed PMID: 19154437; PubMed Central PMCID: PMC2697835.